1.
Bull Exp Biol Med
; 165(3): 344-346, 2018 Jul.
Artículo
en Inglés
| MEDLINE
| ID: mdl-30006879
RESUMEN
The possibility of correction of morphological changes in the myocardium and biochemical parameters of the blood with 3-hydroxypyridine acetylcysteinate in a dose of 25 mg/kg was studied in the model of doxorubicin-induced chronic heart failure in rats. It was found that 3-hydroxypyridine acetylcysteinate in a dose of 25 mg/kg produced less pronounced cardio-protective effect in experimental chronic heart failure than 3-hydroxypyridine succinate.